Study on Doses of Inhaled ALX1 in Adults With Bronchiectasis
Clinical trial NCT07731919 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07731919
- Sponsor
- Vast Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-03-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.